Identifying factors affecting tolerance of ureteral double-J stents

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify predictive factors that contribute to poor tolerance of ureteral double-J stents, which are commonly used in emergency treatments or as preparation for endoscopy following colic nephritis. The research involves administering a questionnaire and the USSQ survey to assess urinary symptoms and the impact of the stent on patients' daily activities. By understanding these factors, the study seeks to improve patient management and outcomes related to stent placement.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patient over 18 years old
* patient who need Ureteral Double-J Stenting

Exclusion Criteria:

* patient under 18 years old,
* Iterative change,
* understanding disorder,
* inability to answer the questionnaire,
* refusal of the patient,
* long-term Ureteral Double-J Stenting (more than 6 month),
* active cancer.

Where it's running

• CHU Amiens-Picardie
  Amiens, France Recruiting

Study contacts

• Study coordinator: Philippe De Sousa, MD
• Email: desousa.philippe@chu-amiens.fr
• Phone: 33+322455775

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Venetoclax added to reduced-intensity conditioning for combined stem cell and kidney transplant

  This trial tests whether adding venetoclax to a reduced-intensity conditioning regimen is safe for adults with blood cancers who are receiving a combined stem cell and kidney transplant from a matched or partially matched donor.

  Recruiting Early Phase 1 Massachusetts General Hospital · Boston, Massachusetts · NCT07358195

• Quality of life with a modified Double-J ureteral stent

  This trial tests whether a modified Double-J stent with a thinner bladder-end loop reduces stent-related symptoms and improves quality of life for adults having ureteroscopy for kidney or ureteral stones.

  Recruiting St. Luke's Clinical Hospital, Russia · Saint Petersburg, Outside U.S./Canada · NCT07275879

• Comparing core stabilization (DNS) and pelvic floor exercises for women with stress urinary leakage

  This project will test whether a 12-week home program of dynamic neuromuscular stabilization (DNS) or pelvic floor muscle training (PFMT) reduces stress urinary leakage and improves quality of life for women with SUI.

  Recruiting Izmir Katip Celebi University · Izmir · NCT07075900

• Effects of Ertugliflozin on liver fat and diabetes control in patients with fatty liver disease

  This study is testing if the medication Ertugliflozin can help adults with Type 2 Diabetes and fatty liver disease reduce liver fat and improve their blood sugar control.

  Recruiting Phase 4 Getz Pharma · Peshawar, KPK · NCT05644717

• Using a special airway device to treat sleep apnea in children with weak muscles

  This study is testing a special airway device to see if it can help children with weak muscles who have sleep apnea breathe better at night without needing surgery.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT05527652

• Combined kidney and blood stem cell transplant from a sibling donor

  This study is testing a new treatment for kidney transplant recipients to see if using a sibling's blood stem cells can help them accept their new kidney without needing lifelong medications to prevent rejection.

  Recruiting Phase 1/2 University of California, Los Angeles · Los Angeles, California · NCT03707262

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.